2014年美国药物性肝损伤会议内容简介*

doi:10.3969/j.issn.1672-5069.2014.06.004

Abstract

Wang Fei, Yang Changqing. Focus on drug induced liver injury：Brief introduction of the 14th AASLD meeting[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 572-575.

[1] Steuerwald NM,Foureau DM,Norton HJ,et al. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. PLoS One,2013,8:e81974.
[2] Kleiner DE,Chalasani NP,Lee WM,et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology,2014,59:661-670.
[3] Brinker AD,Lyndly J,Tonning J,et al. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System（FAERS） database. Drug Saf,2013,36:1169-1178.
[4] Bala S,Petrasek J,Mundkur S,et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced,and inflammatory liver diseases. Hepatology,2012,56:1946-1957.
[5] Wang K,Zhang S,Marzolf B,et al. Circulating microRNAs,potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A,2009,106:4402-4407.
[6] Wang Y,Tang N,Hui T,et al. Identification of endogenous reference genes for RT-qPCR analysis of plasma microRNAs levels in rats with acetaminophen-induced hepatotoxicity. J Appl Toxicol, 2013,23（4）:231-235.
[7] Petrasek J,Iracheta-Vellve A. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc Natl Acad Sci U S A,2013,110:16544-16549.
[8] Wuillemin N,Terracciano L,Beltraminelli H,et al. T cells infiltrate the liver and kill hepatocytes in HLA-B（*）57:01-associated floxacillin-induced liver injury. Am J Pathol,2014,184:1677-1682.
[9] Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis,2009,29:400-411.
[10] Lucena MI,Molokhia M,Shen Y, et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology,2011,141:338-347.
[11] Metushi IG,Lee WM,Uetrecht J. IgG3 is the dominant subtype of anti-isoniazid antibodies in patients with isoniazid-induced liver failure. Chem Res Toxicol,2014,27:738-740.
[12] Metushi IG,Zhu X,Chen X,et al. Mild isoniazid-induced liver injury in humans is associated with an increase in Th17 cells and T cells producing IL-10. Chem Res Toxicol,2014,27:683-689.
[13] Metushi IG,Uetrecht J. Isoniazid-induced liver injury and immune response in mice. J Immunotoxicol,2013,34（12）:3521-3526.
[14] Antoine DJ,Dear JW,Lewis PS,et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology,2013,58:777-787.
[15] Fu D,Mitra K,Sengupta P,et al. Coordinated elevation of mitochondrial oxidative phosphorylation and autophagy help drive hepatocyte polarization. Proc Natl Acad Sci U S A,2013,110:7288-7293.

Focus on drug induced liver injury：Brief introduction of the 14th AASLD meeting

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[6]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[7]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[10]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[11]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[12]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[13]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[14]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.
[15]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.